In conclusion, our study reports the highly expressed ALKBH5 induced by HBV plays a critical role in HCC malignancy by forming a positive feedback loop between HBx and ALKBH5, which could be a potential prognostic indicator and a potential novel therapeutic target for HBV-HCC. Here, ALKBH5 is linked to hepatocellular carcinoma.